Cardio Diagnostics Holdings Inc

Company Profile

Cardio Diagnostics Holdings Inc had its IPO on 2022-01-14 under the ticker symbol CDIOW.

The company operates in the Healthcare sector and Biotechnology industry. Cardio Diagnostics Holdings Inc has a staff strength of 3 employees.

Stock update

Shares of Cardio Diagnostics Holdings Inc opened at $0.06 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.06 - $0.07, and closed at $0.06.

This is a -16.41% slip from the previous day's closing price.

A total volume of 0 shares were traded at the close of the day’s session.

In the last one week, shares of Cardio Diagnostics Holdings Inc have slipped by -34.84%.

Cardio Diagnostics Holdings Inc's Key Ratios

Cardio Diagnostics Holdings Inc has a market cap of $0, indicating a price to book ratio of 0 and a price to sales ratio of 0.

In the last 12-months Cardio Diagnostics Holdings Inc’s revenue was $901 with a gross profit of $0 and an EBITDA of $-1388241. The EBITDA ratio measures Cardio Diagnostics Holdings Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Cardio Diagnostics Holdings Inc’s operating margin was -155853.61% while its return on assets stood at 0% with a return of equity of 0%.

In Q1, Cardio Diagnostics Holdings Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Cardio Diagnostics Holdings Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Cardio Diagnostics Holdings Inc’s profitability.

Cardio Diagnostics Holdings Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.

Cardio Diagnostics Holdings Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$8.55 million

Total Liabilities

$4.39 million

Operating Cash Flow

$0

Capital Expenditure

$52674

Dividend Payout Ratio

0%

Cardio Diagnostics Holdings Inc ended 2024 with $8.55 million in total assets and $0 in total liabilities. Its intangible assets were valued at $8.55 million while shareholder equity stood at $3.42 million.

Cardio Diagnostics Holdings Inc ended 2024 with $0 in deferred long-term liabilities, $4.39 million in other current liabilities, in common stock, $-7024164.00 in retained earnings and $0 in goodwill. Its cash balance stood at $6.71 million and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $0.

Cardio Diagnostics Holdings Inc’s total current assets stands at $8.14 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $0 and inventory worth $0.

In 2024, Cardio Diagnostics Holdings Inc's operating cash flow was $0 while its capital expenditure stood at $52674.

Comparatively, Cardio Diagnostics Holdings Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$0.06

52-Week High

$0.95

52-Week Low

$0.0425

Analyst Target Price

$

Cardio Diagnostics Holdings Inc stock is currently trading at $0.06 per share. It touched a 52-week high of $0.95 and a 52-week low of $0.95. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.13 and 200-day moving average was $0 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.